CSF1R and chronic kidney disease: Moreover, the EPO-induced increase in CD115+ Pro-B cells observed in the control mice was absent in the cKD mice (Figure 5E) while the fraction of Pro-B cells out of total BM cells was not altered as a result of EPO treatment (Figure 5F).